slides · global inventory
Data Story Arc
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 2,275
Current window 1,891-1,920
Pages 76
Rows per page 30
Tool
1,891-1,920 of 2,275
13
The slide uses a 5-step process flow diagram to explain the technical methodology.Absci | Investor Presentation Deck | 48 slides · Absci
Pitch deck Investor relations Beat · Solution1 hit
10
The slide uses a dual-column table structure to categorize clients into 'Brands' and 'Retailers', highlighting both longevity and service breadth.Advantage Solutions | Investor Presentation Deck | 28 slides · Advantage Solutions
Pitch deck Investor relations 1 hit
20
The slide demonstrates bio-equivalence in binding affinity to a specific T-cell population.Aeglea BioTherapeutics | Investor Presentation Deck | 56 slides · Aeglea BioTherapeutics
Pitch deck Investor relations Beat · Solution (Provide relief)Loop · Quick Win Big Bet1 hit
25
Includes a process diagram showing inputs (models, schedules, ERP), constraints, and outputs (maps, timelines, charts).Bigbear AI | Investor Presentation Deck | 29 slides · BigBear.ai
Pitch deck Investor relations 1 hit
21
The diagram uses a tree structure to categorize patient outcomes (off treatment vs on treatment, further broken down by SD and PR).Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
39
The chart shows a statistically significant (***) improvement in survival for the ERAS-801 group compared to the control and other standard-of-care inhibitors.Erasca | Investor Presentation Deck | 56 slides · Erasca
Pitch deck Investor relations 1 hit
17
Kaplan-Meier survival analysis showing statistically significant improvement in PFS for matched treatments.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations Beat · Evidence & Proof1 hit
70
The image shows a protein binding site with color-coded regions (Donor, Apolar, Acceptor) indicating chemical properties.Exscientia | Investor Presentation Deck | 75 slides · Exscientia
Pitch deck Investor relations 1 hit
12
The slide uses a process flow diagram to illustrate the company's proprietary data infrastructure.FiscalNote | Investor Presentation Deck | 32 slides · FiscalNote
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
10
Includes specific clinical study citation (Zacherl et al. 2021).Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations Beat · Market SizeLoop · Quick Win Big Bet1 hit
23
The slide provides a snapshot of the company's financial health and capital structure.Fusion Pharmaceuticals | Investor Presentation Deck | 33 slides · Fusion Pharmaceuticals
Pitch deck Investor relations 1 hit
15
The slide uses a grid layout to present various KPIs.Gogoro | Investor Presentation Deck | 27 slides · Gogoro
Pitch deck Investor relations Beat · Taiwan Market Status UpdateLoop · Quick Win Big Bet1 hit
07
The slide highlights historical performance metrics to demonstrate long-term growth commitment.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
09
The chart combines a grouped bar chart for financial balances with a line chart for relationship counts.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
13
The slide uses two line charts to show downward trends in credit risk metrics from 2017 to 2Q 2023.Heartland Financial USA | Results Presentation Deck | 53 slides · HTLF
Conference presentation Investor relations Beat · Rising SuccessLoop · Cost Of Inaction1 hit
35
The chart is a conceptual visualization of 100% of patients achieving 4 months mPFS.Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Impact & Next StepsLoop · Pareto Focus1 hit
41
Includes two sets of charts: tumor volume line graphs and survival curves. References Abouzeid et al. (2013/2014).Immix Biopharma | Investor Presentation Deck | 49 slides · Immix Biopharma
Pitch deck Investor relations Beat · Solution & Approach1 hit
11
The chart demonstrates the efficacy of NXC-201 (formerly HBI0101) in clearing diseased cells.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Interest1 hit
36
Slide contains three distinct data visualizations comparing IMX-110 against standard of care or historical benchmarks.Immix Biopharma | Investor Presentation Deck | 58 slides · Immix Biopharma
Pitch deck Investor relations Beat · Desire1 hit
47
Includes a line chart showing % change over time and a summary table of patient-level degradation data.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Loop · Golden Circle1 hit
26
The slide outlines the governance and monitoring of the supply chain.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations 1 hit
16
The slide defines DCR and provides a comparative analysis against standard of care (SOC) in third-line therapy.MAIA Biotechnology | Investor Presentation Deck | 35 slides · MAIA Biotechnology
Pitch deck Investor relations 1 hit
33
Includes detailed footnotes regarding yield calculation and dividend-paying companies.Main Street Capital | Fixed Income Presentation Deck | 42 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
23
The slide shows quantitative radiance data (p/s/cm²/sr) comparing control groups to PS-NP LUC mRNA groups at various time points.Matinas BioPharma | Investor Presentation Deck | 28 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
18
The slide highlights high survival rates, particularly in the <10kg group which traditionally receives no therapy.Nuwellis | Investor Presentation Deck | 29 slides · Nuwellis
Pitch deck Investor relations Loop · Jobs To Be Done1 hit
21
The slide uses a process diagram to contrast two distinct R&D workflows.OmniAb | Investor Presentation Deck | 35 slides · OmniAb
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
24
The slide uses a callout box to emphasize the strategic implication of the data.Rent The Runway | Results Presentation Deck | 34 slides · Rent The Runway
Conference presentation Investor relations 1 hit
20
The table lists historical investment data including advances, recoupment rates, and returns.Reservoir | Investor Presentation Deck | 35 slides · Reservoir
Pitch deck Investor relations 1 hit
10
The chart uses an area plot to represent DAU growth, with product features annotated as milestones along the curve.Snap Inc | Investor Presentation Deck | 50 slides · Snap Inc.
Pitch deck Investor relations Beat · Solution1 hit
23
The slide uses a two-column layout to contrast 'Winning Science' (the R&D input) with 'Application at Scale' (the market output).Unilever | Investor Conference Presentation Deck | 32 slides · Unilever
Conference presentation Investor relations Beat · Impact & Next StepsLoop · Quick Win Big Bet1 hit